Cargando…

The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy

PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–as...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guan, Dong, Jie, Wang, Jinbao, Cao, Dongbing, Zhang, Xin, Cao, Zhiqiang, Lu, Guangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402835/
https://www.ncbi.nlm.nih.gov/pubmed/32543025
http://dx.doi.org/10.1002/cam4.3189
_version_ 1783566834265489408
author Li, Guan
Dong, Jie
Wang, Jinbao
Cao, Dongbing
Zhang, Xin
Cao, Zhiqiang
Lu, Guangming
author_facet Li, Guan
Dong, Jie
Wang, Jinbao
Cao, Dongbing
Zhang, Xin
Cao, Zhiqiang
Lu, Guangming
author_sort Li, Guan
collection PubMed
description PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–assisted surgical navigation (MRASN) in LN. PATIENTS AND METHODS: A total of 100 patients with stage T1N0M0 renal tumors who underwent laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN) were prospectively enrolled and divided into a mixed‐reality‐assisted laparoscopic nephrectomy (MRALN) group (n = 50) and a non–mixed‐reality‐assisted laparoscopic nephrectomy (non‐MRALN) group (n = 50). All patients underwent renal contrast‐enhanced CT scans. The CT DICOM data of all patients in the MRALN group were imported into the mixed‐reality (MR) postprocessing workstation and underwent holographic three‐dimensional visualization (V3D) modeling and MR displayed, respectively. We adopted the Likert scale to evaluate the clinical application value of MRASN. The consistency of evaluators was assessed using the Cohen kappa coefficient (k). RESULTS: No significant differences in patient demographic indicators between the MRALN group and the non‐MRALN group (P > .05). The subjective score of MRASN clinical application value in operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication were higher in the MRASN group than in the non‐MRASN group (all P < .001). There were significantly more patients for whom LPN was successfully implemented in the MRALN group than in the non‐MRALN group (82% vs 46%, P < .001). The MRALN group had a shorter operative time (OT) and warm ischemia time (WIT) and less estimated blood loss (EBL) than the non‐MRALN group (all P < .001). CONCLUSION: MRASN is helpful for operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication. MRALN may effectively improve the successful implementation rate of LPN and reduce the OT, WIT, and EBL.
format Online
Article
Text
id pubmed-7402835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74028352020-08-06 The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy Li, Guan Dong, Jie Wang, Jinbao Cao, Dongbing Zhang, Xin Cao, Zhiqiang Lu, Guangming Cancer Med Clinical Cancer Research PURPOSE: Laparoscopic nephrectomy (LN) has become the preferred method for renal cell carcinoma (RCC). Adequate preoperative assessment or intraoperative navigation is key to the successful implementation of LN. The aim of this study was to evaluate the clinical application value of mixed‐reality–assisted surgical navigation (MRASN) in LN. PATIENTS AND METHODS: A total of 100 patients with stage T1N0M0 renal tumors who underwent laparoscopic partial nephrectomy (LPN) or laparoscopic radical nephrectomy (LRN) were prospectively enrolled and divided into a mixed‐reality‐assisted laparoscopic nephrectomy (MRALN) group (n = 50) and a non–mixed‐reality‐assisted laparoscopic nephrectomy (non‐MRALN) group (n = 50). All patients underwent renal contrast‐enhanced CT scans. The CT DICOM data of all patients in the MRALN group were imported into the mixed‐reality (MR) postprocessing workstation and underwent holographic three‐dimensional visualization (V3D) modeling and MR displayed, respectively. We adopted the Likert scale to evaluate the clinical application value of MRASN. The consistency of evaluators was assessed using the Cohen kappa coefficient (k). RESULTS: No significant differences in patient demographic indicators between the MRALN group and the non‐MRALN group (P > .05). The subjective score of MRASN clinical application value in operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication were higher in the MRASN group than in the non‐MRASN group (all P < .001). There were significantly more patients for whom LPN was successfully implemented in the MRALN group than in the non‐MRALN group (82% vs 46%, P < .001). The MRALN group had a shorter operative time (OT) and warm ischemia time (WIT) and less estimated blood loss (EBL) than the non‐MRALN group (all P < .001). CONCLUSION: MRASN is helpful for operative plan formulation, intraoperative navigation, remote consultation, teaching guidance, and doctor‐patient communication. MRALN may effectively improve the successful implementation rate of LPN and reduce the OT, WIT, and EBL. John Wiley and Sons Inc. 2020-06-15 /pmc/articles/PMC7402835/ /pubmed/32543025 http://dx.doi.org/10.1002/cam4.3189 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Li, Guan
Dong, Jie
Wang, Jinbao
Cao, Dongbing
Zhang, Xin
Cao, Zhiqiang
Lu, Guangming
The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title_full The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title_fullStr The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title_full_unstemmed The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title_short The clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
title_sort clinical application value of mixed‐reality‐assisted surgical navigation for laparoscopic nephrectomy
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402835/
https://www.ncbi.nlm.nih.gov/pubmed/32543025
http://dx.doi.org/10.1002/cam4.3189
work_keys_str_mv AT liguan theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT dongjie theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT wangjinbao theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT caodongbing theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT zhangxin theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT caozhiqiang theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT luguangming theclinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT liguan clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT dongjie clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT wangjinbao clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT caodongbing clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT zhangxin clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT caozhiqiang clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy
AT luguangming clinicalapplicationvalueofmixedrealityassistedsurgicalnavigationforlaparoscopicnephrectomy